Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.62 |
| ▸ | TSHR | P16473 | 5/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | RELA | Q04206 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | CHKA | P35790 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7879117 | 0.97 | — | — | |
| SCHEMBL21208167 | 0.97 | ALDH1A1 (0.67) | ALDH1A1TSHRHSD17B10ALOX15MAPK1 | |
| SCHEMBL10557768 | 0.97 | ALDH1A1 (0.67) | ALDH1A1TSHRHSD17B10ALOX15MAPK1 | |
| SCHEMBL8277 | 0.97 | — | — | |
| SCHEMBL16187039 | 0.97 | — | — | |
| SCHEMBL17046164 | 0.93 | ALDH1A1 (0.62) | ALDH1A1TSHRHSD17B10ALOX15MAPK1 | |
| Trimethylammonium SCHEMBL2531877 | 0.93 | ALDH1A1 (0.62) | ALDH1A1TSHRHSD17B10ALOX15MAPK1 | |
| Water SCHEMBL6758084 | 0.93 | ALDH1A1 (0.62) | ALDH1A1TSHRHSD17B10ALOX15MAPK1 | |
| Bromide SCHEMBL252099 | 0.93 | ALDH1A1 (0.62) | ALDH1A1TSHRHSD17B10ALOX15MAPK1 | |
| SCHEMBL7983815 | 0.93 | ALDH1A1 (0.62) | ALDH1A1TSHRHSD17B10ALOX15MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106221874-A | Weaving lubricant that a kind of lubricant effect is excellent and preparation method thereof | 南通泰利达化工有限公司 | 2016-12-14 | — | — | CN | claimed |
| EP-2868659-B1 | Method for producing optically active naphthalene compound | MITSUBISHI TANABE PHARMA CORP (JP) | 2016-05-04 | — | — | EP | claimed |
| US-9181217-B2 | Method for producing optically active naphthalene compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-11-10 | — | — | US | claimed |
| US-20150152082-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-06-04 | — | — | US | claimed |
| EP-2868659-A1 | Method for producing optically active naphthalene compound | Mitsubishi Tanabe Pharma Corporation (JP) | 2015-05-06 | — | — | EP | claimed |
| EP-2749558-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | Mitsubishi Tanabe Pharma Corporation (JP) | 2014-07-02 | — | — | EP | claimed |
| US-8637703-B2 | Methods for synthesizing ammonia borane | THE OHIO STATE UNIVERSITY (US) | 2014-01-28 | — | — | US | claimed |
| US-20130237708-A1 | Optically Active Cyclic Alcohol Compound And Method For Preparing The Same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2013-09-12 | — | — | US | claimed |
| EP-2007743-B1 | METHODS FOR SYNTHESIZING AMMONIA BORANE | UNIV OHIO STATE (US) | 2013-06-12 | — | — | EP | claimed |
| CN-101275228-B | Electroless plating bath and method for producing high-temperature apparatus member using the bath | EBARA CORP | 2012-11-21 | — | — | CN | claimed |
| EP-1944291-B1 | Optically active cyclic alcohol compound and method for producing same | MITSUBISHI TANABE PHARMA CORP (JP) | 2012-06-13 | — | — | EP | claimed |
| US-20120014857-A1 | METHODS FOR SYNTHESIZING AMMONIA BORANE | THE OHIO STATE UNIVERSITY (US) | 2012-01-19 | — | — | US | claimed |
| US-7977508-B2 | Methods for synthesizing ammonia borane | THE OHIO STATE UNIVERSITY (US) | 2011-07-12 | — | — | US | claimed |
| US-20100152451-A1 | OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PREPARING THE SAME | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-06-17 | — | — | US | claimed |
| US-20090104102-A1 | METHODS FOR SYNTHESIZING AMMONIA BORANE | THE OHIO STATE UNIVERSITY | 2009-04-23 | — | — | US | claimed |
| EP-2007743-A2 | METHODS FOR SYNTHESIZING AMMONIA BORANE | The Ohio State University (US) | 2008-12-31 | — | — | EP | claimed |
| EP-1944291-A1 | OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PRODUCING SAME | Mitsubishi Tanabe Pharma Corporation (JP) | 2008-07-16 | — | — | EP | claimed |
| WO-2007120511-A2 | METHODS FOR SYNTHESIZING AMMONIA BORANE | THE OHIO STATE UNIVERSITY (US) | 2007-10-25 | — | — | WO | claimed |
| US-20050148781-A1 | Process for the asymmetric synthesis of dihydrobenzoxathins | SONG ZHIGUO J (US) | 2005-07-07 | — | — | US | claimed |
| US-20230357507-A1 | SULFUR-CONTAINING POLYMER, METHOD FOR PRODUCING SAME, AND SULFUR-CONTAINING POLYMER COMPOSITION | NIPPON SHOKUBAI CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| EP-4220242-A1 | SULFUR-CONTAINING POLYMER, METHOD FOR PRODUCING SAME, AND SULFUR-CONTAINING POLYMER COMPOSITION | Nippon Shokubai Co., Ltd. (JP) | 2023-08-02 | — | — | EP | disclosed |
| US-10392345-B2 | Crystal of salt of novel 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 2019-08-27 | — | — | US | disclosed |
| US-10370254-B2 | Method for producing borazane | AIRBUS SAFRAN LAUNCHERS SAS (FR) | 2019-08-06 | — | — | US | disclosed |
| EP-3145863-B1 | METHOD FOR PRODUCING BORAZANE | ARIANEGROUP SAS (FR) | 2018-10-17 | — | — | EP | disclosed |
| US-20180148409-A1 | CRYSTAL OF SALT OF NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | UBE CORPORATION (JP) | 2018-05-31 | — | — | US | disclosed |
| EP-3321262-A1 | SERINE/THREONINE KINASE INHIBITORS | Array Biopharma, Inc. (US) | 2018-05-16 | — | — | EP | disclosed |
| EP-3299357-A1 | CRYSTAL OF SALT OF NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 2018-03-28 | — | — | EP | disclosed |
| US-9834448-B2 | Preparation of amine-boranes, including ammonia borane | PURDUE RESEARCH FOUNDATION (US) | 2017-12-05 | — | — | US | disclosed |
| US-20170305750-A1 | METHOD FOR PRODUCING BORAZANE | AIRBUS SAFRAN LAUNCHERS SAS (FR) | 2017-10-26 | — | — | US | disclosed |
| US-9663463-B2 | 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purpose | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 2017-05-30 | — | — | US | disclosed |
| EP-3145863-A1 | METHOD FOR PRODUCING BORAZANE | Airbus Safran Launchers SAS (FR) | 2017-03-29 | — | — | EP | disclosed |
| US-20160280645-A1 | NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSE | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 2016-09-29 | — | — | US | disclosed |
| EP-3072884-A1 | NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 2016-09-28 | — | — | EP | disclosed |
| EP-2868659-B1 | Method for producing optically active naphthalene compound | MITSUBISHI TANABE PHARMA CORP (JP) | 2016-05-04 | — | — | EP | disclosed |
| US-20160101984-A1 | PREPARATION OF AMINE-BORANES, INCLUDING AMMONIA BORANE | PURDUE RESEARCH FOUNDATION (US) | 2016-04-14 | — | — | US | disclosed |
| WO-2015177483-A1 | METHOD FOR PRODUCING BORAZANE | HERAKLES (FR) | 2015-11-26 | — | — | WO | disclosed |
| US-9181217-B2 | Method for producing optically active naphthalene compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-11-10 | — | — | US | disclosed |
| EP-2563762-B1 | METHOD FOR PRODUCING SUBSTITUTED PYRIDIN-2-ONE | BAYER IP GMBH (DE) | 2015-07-22 | — | — | EP | disclosed |
| US-20150152082-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-06-04 | — | — | US | disclosed |
| EP-2868659-A1 | Method for producing optically active naphthalene compound | Mitsubishi Tanabe Pharma Corporation (JP) | 2015-05-06 | — | — | EP | disclosed |
| US-8802860-B2 | Method for producing substituted pyridin-2-one | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-08-12 | — | — | US | disclosed |
| EP-2749558-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | Mitsubishi Tanabe Pharma Corporation (JP) | 2014-07-02 | — | — | EP | disclosed |
| US-8754221-B2 | Optically active cyclic alcohol compound and method for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2014-06-17 | — | — | US | disclosed |
| US-8637703-B2 | Methods for synthesizing ammonia borane | THE OHIO STATE UNIVERSITY (US) | 2014-01-28 | — | — | US | disclosed |
| EP-2675811-A1 | TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION | Boehringer Ingelheim International GmbH (DE) | 2013-12-25 | — | — | EP | disclosed |
| US-20130296551-A1 | 7-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF | DAIICHI SANKYO CO LTD (JP) | 2013-11-07 | — | — | US | disclosed |
| US-20130237708-A1 | Optically Active Cyclic Alcohol Compound And Method For Preparing The Same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2013-09-12 | — | — | US | disclosed |
| EP-2463268-B1 | 4-(Aminomethyl)benzoic acids as intermediates for the preparation of chymase inhibiting 1,4-diazepan-2,5-dione compounds | DAIICHI SANKYO CO LTD (JP) | 2013-08-28 | — | — | EP | disclosed |
| EP-2371820-B1 | Optically active cyclic alcohol compound and method for preparing the same | MITSUBISHI TANABE PHARMA CORP (JP) | 2013-08-28 | — | — | EP | disclosed |
| US-8507714-B2 | 7-membered ring compound and method of production and pharmaceutical application thereof | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-08-13 | — | — | US | disclosed |
| US-8471028-B2 | Optically active cyclic alcohol compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2013-06-25 | — | — | US | disclosed |
| EP-2007743-B1 | METHODS FOR SYNTHESIZING AMMONIA BORANE | UNIV OHIO STATE (US) | 2013-06-12 | — | — | EP | disclosed |
| US-20130116443-A1 | METHOD FOR PRODUCING SUBSTITUTED PYRIDIN-2-ONE | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-05-09 | — | — | US | disclosed |
| EP-2563762-A1 | METHOD FOR PRODUCING SUBSTITUTED PYRIDIN-2-ONE | Bayer Intellectual Property GmbH (DE) | 2013-03-06 | — | — | EP | disclosed |
| EP-2536733-A1 | TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION | Boehringer Ingelheim International GmbH (DE) | 2012-12-26 | — | — | EP | disclosed |
| CN-101275228-B | Electroless plating bath and method for producing high-temperature apparatus member using the bath | EBARA CORP | 2012-11-21 | — | — | CN | disclosed |
| CN-101469420-B | Electroless gold-plating method and electronic component | UYEMURA C & CO LTD | 2012-10-03 | — | — | CN | disclosed |
| CN-102690804-A | Polyethylene-glycol-modified recombinant homosapiensarginase I, preparation method thereof and application thereof | BEIJING SL PHARMACEUTICAL CO LTD | 2012-09-26 | — | — | CN | disclosed |
| CN-101316813-B | Process for preparing vitamin D derivatives by conversion | CHUGAI PHARMACEUTICAL CO LTD | 2012-09-05 | — | — | CN | disclosed |
| WO-2012110599-A1 | TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-08-23 | — | — | WO | disclosed |
| EP-1820798-B1 | 7-MEMBERED RING COMPOUND, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL USE THEREOF | DAIICHI SANKYO CO LTD (JP) | 2012-08-22 | — | — | EP | disclosed |
| EP-1944291-B1 | Optically active cyclic alcohol compound and method for producing same | MITSUBISHI TANABE PHARMA CORP (JP) | 2012-06-13 | — | — | EP | disclosed |
| EP-2463268-A1 | Aminomethyl-substituted aromatic acids as intermediates for the preparation of chymase inhibiting 1,4-diazepan-2,5-dione compounds | Daiichi Sankyo Company, Limited (JP) | 2012-06-13 | — | — | EP | disclosed |
| US-8188073-B2 | Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2012-05-29 | — | — | US | disclosed |
| US-8173824-B2 | Process for producing vitamin D derivative using convergent method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2012-05-08 | — | — | US | disclosed |
| EP-1984345-B9 | BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS | MITSUBISHI TANABE PHARMA CORP (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-20120014857-A1 | METHODS FOR SYNTHESIZING AMMONIA BORANE | THE OHIO STATE UNIVERSITY (US) | 2012-01-19 | — | — | US | disclosed |
| WO-2011134963-A1 | METHOD FOR PRODUCING SUBSTITUTED PYRIDIN-2-ONE | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2011-11-03 | — | — | WO | disclosed |
| US-8049006-B2 | 7-membered ring compound and method of production and pharmaceutical application thereof | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| US-20110251185-A1 | BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS | IIJIMA TORU | 2011-10-13 | — | — | US | disclosed |
| EP-2371820-A1 | Optically active cyclic alcohol compound and method for preparing the same | Mitsubishi Tanabe Pharma Corporation (JP) | 2011-10-05 | — | — | EP | disclosed |
| EP-1984345-B1 | BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS | MITSUBISHI TANABE PHARMA CORP (JP) | 2011-08-31 | — | — | EP | disclosed |
| WO-2011101424-A1 | TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-08-25 | — | — | WO | disclosed |
| US-7998956-B2 | Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-08-16 | — | — | US | disclosed |
| US-20110196157-A1 | OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PREPARING THE SAME | MITSUBISHI TANABE PHARMA CORPORATION | 2011-08-11 | — | — | US | disclosed |
| US-7989627-B2 | Optically active cyclic alcohol compound and method for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-08-02 | — | — | US | disclosed |
| US-7977508-B2 | Methods for synthesizing ammonia borane | THE OHIO STATE UNIVERSITY (US) | 2011-07-12 | — | — | US | disclosed |
| US-20110166342-A1 | 7-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-07-07 | — | — | US | disclosed |
| US-7888348-B2 | 7-membered ring compound and method of production and pharmaceutical application thereof | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-02-15 | — | — | US | disclosed |
| US-20100217020-A1 | PROCESS FOR PRODUCING VITAMIN D DERIVATIVE USING CONVERGENT METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2010-08-26 | — | — | US | disclosed |
| US-20100152451-A1 | OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PREPARING THE SAME | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20090264469-A1 | NOVEL DICARBOXYLIC ACID DERIVATIVES | BIO-PROJET (FR) | 2009-10-22 | — | — | US | disclosed |
| US-20090253683-A1 | 7-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF | ASUBIO PHARMA CO., LTD (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090111796-A1 | 7-membered ring compound and method of production and pharmaceutical application thereof | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-04-30 | — | — | US | disclosed |
| US-20090104102-A1 | METHODS FOR SYNTHESIZING AMMONIA BORANE | THE OHIO STATE UNIVERSITY | 2009-04-23 | — | — | US | disclosed |
| EP-2025672-A1 | SEVEN-MEMBERED RING COMPOUND, PRODUCTION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF | Asubio Pharma Co., Ltd. (JP) | 2009-02-18 | — | — | EP | disclosed |
| US-20090023716-A1 | Benzoxazines and Related Nitrogen-Containing Heterobicyclic Compounds Useful as Mineralocorticoid Receptor Modulating Agents | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-2007743-A2 | METHODS FOR SYNTHESIZING AMMONIA BORANE | The Ohio State University (US) | 2008-12-31 | — | — | EP | disclosed |
| EP-1984345-A1 | BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS | Mitsubishi Tanabe Pharma Corporation (JP) | 2008-10-29 | — | — | EP | disclosed |
| EP-1955999-A1 | METHOD FOR PRODUCING VITAMIN D DERIVATIVE BY USING CONVERGENT METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2008-08-13 | — | — | EP | disclosed |
| EP-1944291-A1 | OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PRODUCING SAME | Mitsubishi Tanabe Pharma Corporation (JP) | 2008-07-16 | — | — | EP | disclosed |
| EP-1650186-B1 | Novel dicarboxylic acid derivatives | BIOPROJET SOC CIV (FR) | 2008-06-04 | — | — | EP | disclosed |
| WO-2007120511-A2 | METHODS FOR SYNTHESIZING AMMONIA BORANE | THE OHIO STATE UNIVERSITY (US) | 2007-10-25 | — | — | WO | disclosed |
| CN-101048458-A | Elastomeric reactor blend compositions | EXXONMOBIL CHEM PATENTS INC (US) | 2007-10-03 | — | — | CN | disclosed |
| EP-1820798-A1 | 7-MEMBERED RING COMPOUND, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL USE THEREOF | Asubio Pharma Co., Ltd. (JP) | 2007-08-22 | — | — | EP | disclosed |
| WO-2007089034-A1 | BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-08-09 | — | — | WO | disclosed |
| WO-2006043149-A9 | NOVEL DICARBOXYLIC ACID DERIVATIVES | BIOPROJET SOC CIV (FR) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006043149-A2 | NOVEL DICARBOXYLIC ACID DERIVATIVES | BIOPROJET (FR) | 2006-04-27 | — | — | WO | disclosed |
| EP-1650186-A1 | Novel dicarboxylic acid derivatives | BIOPROJET (FR) | 2006-04-26 | — | — | EP | disclosed |
| US-20050148781-A1 | Process for the asymmetric synthesis of dihydrobenzoxathins | SONG ZHIGUO J (US) | 2005-07-07 | — | — | US | disclosed |
| CN-1100666-C | Breathable laminate including filled film and continuous film | KIMBERLY CLARK CO (US) | 2003-02-05 | — | — | CN | disclosed |
| CN-1361759-A | 6-hydroxy-2-naphthyl carbinol and process for producing the same | MITSUBISHI CHEM CORP (JP) | 2002-07-31 | — | — | CN | disclosed |
| CN-1241964-A | Breathable laminate comprising filled film and continuous film | KIMBERLY CLARK CO (US) | 2000-01-19 | — | — | CN | disclosed |
| CN-1241964-A | Breathable laminate comprising filled film and continuous film | KIMBERLY CLARK CO (US) | 2000-01-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (20 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10392345-B2 | Crystal of salt of novel 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof | OPRM1, OPRD1, OPRK1 | ALDH1A1 547/4885TSHR 663/4885HSD17B10 452/4885 |
| US-20130116443-A1 | METHOD FOR PRODUCING SUBSTITUTED PYRIDIN-2-ONE | PNPO, CYP4B1, DPYD | ALDH1A1 488/4885TSHR 2170/4885HSD17B10 995/4885 |
| US-20100217020-A1 | PROCESS FOR PRODUCING VITAMIN D DERIVATIVE USING CONVERGENT METHOD | CYP2R1, CYP24A1, VDR | ALDH1A1 339/4885TSHR 554/4885HSD17B10 99/4885 |
| US-20150152082-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | HRH1, HRH4, RB1 | ALDH1A1 343/4885TSHR 1344/4885HSD17B10 1726/4885 |
| US-20090111796-A1 | 7-membered ring compound and method of production and pharmaceutical application thereof | CMA1, CPA3, SI | ALDH1A1 1889/4885TSHR 3978/4885HSD17B10 608/4885 |
| US-20170305750-A1 | METHOD FOR PRODUCING BORAZANE | BAD, BAX, BCL2A1 | ALDH1A1 3673/4885TSHR 3692/4885HSD17B10 3237/4885 |
| US-20110196157-A1 | OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PREPARING THE SAME | ADH1C, ADH1A, ADH5 | ALDH1A1 25/4885TSHR 1161/4885HSD17B10 325/4885 |
| US-20100152451-A1 | OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PREPARING THE SAME | ADH1C, ADH1A, ADH5 | ALDH1A1 25/4885TSHR 1161/4885HSD17B10 325/4885 |
| US-20090264469-A1 | NOVEL DICARBOXYLIC ACID DERIVATIVES | S1PR2, S1PR1, S1PR5 | ALDH1A1 1287/4885TSHR 1450/4885HSD17B10 1364/4885 |
| US-20130296551-A1 | 7-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF | CMA1, CPA3, SI | ALDH1A1 1889/4885TSHR 3978/4885HSD17B10 608/4885 |
| US-20160101984-A1 | PREPARATION OF AMINE-BORANES, INCLUDING AMMONIA BORANE | SAT1, BCAT2, NAAA | ALDH1A1 3055/4885TSHR 1086/4885HSD17B10 3898/4885 |
| US-20160280645-A1 | NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSE | OPRM1, OPRD1, OPRK1 | ALDH1A1 610/4885TSHR 384/4885HSD17B10 628/4885 |
| US-20090253683-A1 | 7-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF | CMA1, CPA3, SI | ALDH1A1 1889/4885TSHR 3978/4885HSD17B10 608/4885 |
| US-20050148781-A1 | Process for the asymmetric synthesis of dihydrobenzoxathins | HSD17B11, CBS, DHPS | ALDH1A1 373/4885TSHR 1818/4885HSD17B10 95/4885 |
| US-20130237708-A1 | Optically Active Cyclic Alcohol Compound And Method For Preparing The Same | ADH1C, ADH1A, ADH5 | ALDH1A1 25/4885TSHR 1161/4885HSD17B10 325/4885 |
| US-20180148409-A1 | CRYSTAL OF SALT OF NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | OPRM1, OPRD1, OPRK1 | ALDH1A1 547/4885TSHR 663/4885HSD17B10 452/4885 |
| US-20090023716-A1 | Benzoxazines and Related Nitrogen-Containing Heterobicyclic Compounds Useful as Mineralocorticoid Receptor Modulating Agents | NR3C2, MC2R, NR3C1 | ALDH1A1 2133/4885TSHR 106/4885HSD17B10 571/4885 |
| US-20110166342-A1 | 7-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF | CMA1, CPA3, SI | ALDH1A1 1889/4885TSHR 3978/4885HSD17B10 608/4885 |
| US-10370254-B2 | Method for producing borazane | BAD, BAX, BCL2A1 | ALDH1A1 3673/4885TSHR 3692/4885HSD17B10 3237/4885 |
| US-20110251185-A1 | BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS | NR3C2, MC2R, NR3C1 | ALDH1A1 2133/4885TSHR 106/4885HSD17B10 571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.